期刊文献+

年龄对顺式阿曲库铵肌松效应的影响 被引量:7

Influence of age on neuromuscular block effect of cisatracurium
下载PDF
导出
摘要 目的观察并比较单次静脉注射2倍95%的有效药物剂量(ED95)顺式阿曲库铵对不同年龄患者的肌松效应。方法将60例按美国麻醉协会(ASA)标准定为Ⅰ~Ⅱ级的患者分为幼儿组(3~7岁)、青壮年组(18~65岁)和老年组(≥65岁),每组20例。麻醉诱导期间单次注入2倍ED95顺式阿曲库铵,用TOF Watch加速度仪进行肌肉松弛监测,观察起效时间、阻滞维持时间、临床作用时间、体内作用时间和恢复指数。结果 3组间气管插管评级差异无统计学意义(P>0.05)。幼儿组肌松起效时间、阻滞维持时间、临床作用时间及体内作用时间均明显短于青壮年组和老年组,差异有统计学意义(P<0.05)。3组的肌松恢复指数比较差异无统计学意义(P>0.05)。结论幼儿对顺式阿曲库铵更为敏感,起效快,肌松阻滞维持时间和作用时间短,与成人的肌松效应相似;肌松恢复时间与年龄无关,2倍ED95诱导剂量对不同年龄的患者均安全有效。 Objective To investigate the neuromuscular block effect of intravenous injection of two times of 95% effective dose(ED95) of cisatracurium in patients with different ages. Methods Sixty patients with ASA Ⅰ-Ⅱ were divided into children group(3 to 7 years old),youth group(18 to 65 years old) and elder group(≥ 65 years old),with 20 patients in each group.Cisatracurium of two times of ED95 was injected during anesthesia induction,neuromuscular block was monitored with TOF Watch acceleration instrument,and the time of neuromuscular block onset,duration of blockade maintenance,duration of clinical action,duration of in vivo action and neuromuscular block recovery index were obtained. ResultsThere was no significant difference in trachea intubation grading among three groups(P0.05).The time of neuromuscular block onset,duration of blockade maintenance,duration of clinical action and duration of in vivo action in children group were significantly shorter than those in youth group and elder group(P0.05).There was no significant difference in neuromuscular block recovery index among three groups(P0.05). Conclusion Children are more sensitive than adults to cisatracurium,with faster neuromuscular block onset,shorter duration of blockade maintenance and shorter duration of clinical action.The neuromuscular block recovery time is not related to age,and two times of ED95 of cisatracurium is safe and effective for patients with different ages.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2012年第1期90-92,共3页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海交通大学医学院麻醉学重点学科(2008)~~
关键词 年龄 顺式阿曲库铵 肌松效应 age cisatracurium neuromuscular block
  • 相关文献

参考文献12

二级参考文献47

  • 1张新建,徐世元.新肌松药拮抗剂Org25969的研究进展[J].中国医师杂志,2005,7(S1):446-447. 被引量:1
  • 2马皓琳.罗库溴铵的起效及其影响因素[J].国外医学(麻醉学与复苏分册),1996,17(3):141-142. 被引量:18
  • 3向桂芳,罗放,张铁军,张咸伟,田玉科.罗库溴铵联合麻黄素行快速气管插管的临床研究[J].实用医学杂志,2006,22(24):2904-2905. 被引量:6
  • 4上官王宁,连庆泉,李军,陈小玲,FangGao Smith.小儿不同剂量顺式阿曲库铵的肌松作用[J].中华麻醉学杂志,2007,27(1):54-57. 被引量:20
  • 5Kim KS, Cheong MA, Jeon JW, et al. The dose effect of ephedrine on the onset time of Vecuronium [J]. Anesth Analg, 2003, 96 (4): 1042-1046.
  • 6Gopalakrishna MD, Krishna HM, Shenoy UK, et al. The effect of ephedrine on intubating conditions and haemodynamics during rapid tracheal intubation using propofol and rocuronium [J]. Br J Anaesth, 2007, 99 (2): 191-194.
  • 7Komatsu R, Nagata O, Ozakl M, et al. Ephedrine fails to accelerate the onset of neuromuscular block by vecuronium [J]. Anesth Analg, 2003, 97 (2): 480-483.
  • 8Moro ET, Nakamura G, Martino RS, et al. Effect of propofol in combination with ephedrine upon the onset of cisatracurium [J]. Rev Assoc med Bras, 2007, 53 (3): 272-275.
  • 9Albert F, Hans P, Bitar Y, et al. Effect of ephedrine on the onset time of neuromuscular block and intubating conditions after cisatracurium: preliminary results [J]. Aeta Anaesthessial Belg. 2000, 51 (3): 167-171.
  • 10Baraka A. Test dose for prediction of mivacurium sensitivity in the patient with atypical plasma cholinesterase [ J ]. Anesthesiology,1995, 83:1371 - 1372.

共引文献57

同被引文献64

  • 1吴宏亮,叶铁虎,孙莉.镁离子对阿曲库铵神经肌肉传递阻滞时间的影响[J].中国医学科学院学报,2009,31(1):73-76. 被引量:9
  • 2魏嵘,杜晶慧,付月珍,金泉英.顺式阿曲库铵在儿童早期插管中的应用研究[J].上海交通大学学报(医学版),2011,31(11):1625-1627. 被引量:4
  • 3刘新生,张卫,阚全程.不同性别和年龄患者罗库溴铵肌松效应的比较[J].中华麻醉学杂志,2007,27(4):380-381. 被引量:17
  • 4Adams WA, Mark-senior J, Jones RS, et al. Cis-atracurium in dogs with and without polo-systemic shunt. Vel Anaesth Analg,2006,33:17.
  • 5Chen C, Yamaguchi N, Varin F. Studies on the pharmacokinetics of cisatracurium in anesthetized dogs: in vitro-in vivo correlations. Vet Pharmacol Ther,2009,32:571-576.
  • 6Fassbender P, Geldner G, Blobner M, et al. Clinical predictors of duration of action of cisatracurium and rocurium adminis- tered long-term. Am J Crit Care,2009,18:439-455.
  • 7Chen C, Yamaguchi N, Varin F. Dose-dependency of pharma- cokinetics/pharmacodynamic parameters after intravenous bolus doses of cisatracurium. Br J Anesth,2008,101:788-797.
  • 8Welch RM, Brown A, Ravitch J, et al. The in vitro degradation of cisatracurium, the R, Cis-R' -isomer of atracurium, in human and rat plasma. Clin Pharmaeol Ther,1995,58:132-142.
  • 9Woloszczuk-Gebicka B, Wyska E, Grabowski T. Sevoflurane in- creases fade of neuromuscular response to TOF stimulation fol- lowing rocuronium administration in children.A Pk/PD analysis Paediatr Anaesth,2007,17:637-646.
  • 10Nonaka A, Sugawara T, Suzuki S, et al. Pretreatment with lidocaine accelerates onset of vecuronium-induced neuro- muscular blockade. Jpn J Anesthesiol(Masui),2002,51:880-883.

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部